Canton Hathaway »

Neurocrine Biosciences shares owned by Canton Hathaway

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Canton Hathaway from 13F filings

Historical chart of Canton Hathaway investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Canton Hathaway consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Canton Hathaway

Quarter filed Position value Share count Share price at filing
2026-06-30 $152k 900 168.54

More positions owned by Canton Hathaway

Berkshire Hathaway Inc A Cl A (BRK.A)
Vanguard 500 ETF Etf (VOO)
Bloom Energy Corp Class A Com Cl A (BE)
Alphabet Inc Class C cs (GOOG)
Ishares Msci Eafe Etf Etf (EFA)
Spdr Gold Tr Gold Gold Shs (GLD)
Microsoft Corporation (MSFT)
Berkshire Hathaway Inc B Cl B New (BRK.B)
Technology Select Sector SPDR ETF Etf (XLK)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Industrial Select SPDR ETF Etf (XLI)
iShares Russell 2000 Etf (IWM)
Qxo Com New (QXO)
iShares Silver Trust Etf (SLV)

View all positions for Canton Hathaway

Top funds holding Neurocrine Biosciences

BlackRock
Jpmorgan Chase & Co
Dodge & Cox
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
AQR Capital Management
Renaissance Technologies
Geode Capital Management
Two Sigma Investments
Vestal Point Capital
Bnp Paribas Investment Partners
Rtw Investments
Northern Trust
Morgan Stanley

View all funds holding Neurocrine Biosciences